The first new drug approved specifically to treat amyotrophic lateral sclerosis (ALS), commonly referred to a Lou Gehrig’s Disease, in over two decades was approved in less than a year, thanks in large part to the FDA working in conjunction with Mitsubishi Tanabe Pharma Corp. and the ALS Association. Read More »
Allegra drug developer Sanofi supports Bike to Work Day, a day where Americans are urged to ride bicycles to work instead of driving. Read More »
A patent application has been filed for a new cannabinoid-based topical therapy that will treat glaucoma, the second-leading cause of blindness. Read More »
Valeant Pharmaceuticals Inc. and EyeGate Pharmaceuticals have entered an exclusive, global licensing agreement. Read More »
The Academy of Managed Care Pharmacy's members are urging Congress and President Donald Trump's administration to include comprehensive pharmacy benefits in any health care reform bill they attempt to pass. Read More »
Advanced Pharma Inc., which does business as Avella of Houston, is voluntarily recalling unexpired sterile injectable products labeled "latex free" that were produced at the company’s Houston location between Sep. 1, 2016 and Feb. 16, 2017. Read More »
The U.S. Food and Drug Administration has approved Siliq (brodalumab) as a treatment for adults with moderate-to-severe plaque psoriasis. Read More »
CVS Health will nationally sponsor the American Heart Association’s Go Red For Women and pledge to raise $10 million over the next three years in support of life-saving cardiovascular research and education. Read More »
The cost of generic prescription drugs rose at a much slower rate than brand name drugs in 2016, according to an annual national drug index released by Truveris. Read More »
Amgen recently shared positive results for its Fourier Trial, which is evaluating whether Repatha reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease. Read More »
Zimmer Biomet Holdings' Gel-One Cross-linked Hyaluronate has been approved by the U.S. Food and Drug Administration. Read More »
Fred’s Inc.'s plans to buy 865 Rite Aid stores for $950 million is still active. Read More »
Envisia Therapeutics has released an interim analysis on the second cohort of its ENV515 (travoprost XR) Phase 2 trial, which involves patients with glaucoma. Read More »
The American Society of Hospital Pharmacists (ASHP) recently announced that a new AHFS Drug Information (AHFS DI) has been released. Read More »
Portola Pharmaceuticals Inc.'s clinical results from a study will be presented during the International Conference on Malignant Lymphoma. Read More »
GE Healthcare is working alongside of Check-Cap on the development and validation of a cancer-screening process. Read More »
Sandoz AG, part of Novatis, has made an agreement with DURECT Corp. for the marketing of POSIMIR, an analgesic being developed by DURECT. Read More »
Express Scripts has acquired myMatrixx to combine its integrated pharmacy benefit management services with myMatrixx's workers' compensation pharmacy benefits experience. Read More »
60 Degrees Pharmaceuticals' study findings on tafenoquine have been published in Travel Medicine and Infectious Disease. Read More »
Pennsylvania Physician General Dr. Rachel Levine and Dauphin County Coroner Graham Hetrick recently met to discuss prescribing guidelines for opioids and benzodiazepines, known as benzos, and the opioid epidemic. Read More »
Alerts Sign-up
